Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 10,000 shares at $59.93 ($599K) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $599k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.93 | 9,500 | $569K | 95.0% |
| 2 | $60.31 | 500 | $30K | 5.0% |
| Total | $59.95 avg | 10,000 | $599K | 100% |
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |